From ex vivo to in vivo chimeric antigen T cells manufacturing: new horizons for CAR T-cell based therapy

Engineered hypoxia-responsive albumin nanoparticles mediating mitophagy regulation for cancer therapy

Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T

Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments